Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease

Overview of attention for article published in this source, April 2012

Altmetric Badge

Mentioned by

policy: 1 policy source
twitter: 3 X users

wikipedia: 8 Wikipedia pages

Citations

dimensions_citation: 69 Dimensions

Readers on

mendeley: 93 Mendeley
citeulike: 1 CiteULike

Summary Policy documents X Wikipedia Dimensions citations

So far, Dimensions has found 69 publications that cite this research output.

69

The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.

Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease

Article in Cochrane Database of Systematic Reviews (December 2023)

New concept and algorithm for the management of patients with chronic obstructive pulmonary disease

Article in PULMONOLOGIYA (July 2023)

A Comparative Evaluation of Glycopyrronium Bromide, A Long-Acting Muscarinic Antagonist versus Tiotropium Bromide in Triple Therapy of COPD Patients in an Indian Clinical Setting

Article in The Indian Journal of Chest Diseases & Allied Sciences (November 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.